Accessibility & FAQs

We, the Wissenschaftliche Verlagsgesellschaft Stuttgart, are committed to ensuring that our website, our information and our services on drugbase.plus are as accessible as possible to all users, regardless of possible limitations.

We therefore strive to prepare our content in such a way that it can be easily used by people with different abilities. To this end, we are continuously working to improve accessibility and comply with recognized standards, such as the German Accessibility Improvement Act (BFSG).

1. status of compatibility with the requirements 

This website is partially compliant with the recognized standards due to the following incompatibilities and exceptions.

The review is based on an assessment carried out by the tool https://wave.webaim.org in accordance with the legal requirements and globally applicable standards. The home page and an exemplary article page were checked.

Contrasts 

Texts and visual elements have a sufficient contrast ratio.

Keyboard operability 

All interactive components (e.g. forms, buttons, if available) are designed to be accessible via various input methods, such as keyboard or touch.

Language

The website provides a language attribute so that screen readers can select the correct pronunciation for a voice output.

2. non-accessible content 

The content, functions or sections listed below are currently not accessible. These temporary exceptions are due, for example, to disproportionate burdens or technical limitations.  

Alternative texts 

Images and other visual elements (e.g. buttons, links, graphics, if available) do not always contain a text form of the information displayed that can be read by screen readers.

Forms and input fields 

There are form fields without a label. Navigation with screen readers to the form field is difficult.  

Content structure of the website 

Not all content (e.g. tables, lists, if available) is structured and described in such a way that it can be recognized and understood by screen readers.

Headings and page structure 

There are jumps in the heading hierarchy. Assistive technologies, such as screen readers or keyboard operation, can be restricted as a result. 

Use of ARIA labels 

ARIA attributes and roles are not always appropriate.

3. creation of the declaration on accessibility 

This declaration was created on 13.05.2025. 
The statement was last reviewed on (date of last review).  

4 Feedback and contact details 

If you notice any deficiencies with regard to compliance with the accessibility requirements, please do not hesitate to contact us:  

Wissenschaftliche Verlagsgesellschaft Stuttgart
Maybachstraße 8 - 70469 Stuttgart
Postfach 10 10 61 - 70009 Stuttgart
Telephone: 0711 2582 0
Internet: www.Wissenschaftliche-Verlagsgesellschaft.de

barrierefreiheit@dav-medien.de

Please send us the URL of the affected website and a description of the barrier.

We will endeavor to process your request as quickly as possible.  

5. arbitration procedure  

If you are of the opinion that (drugbase.plus) is not accessible without barriers, you can inform our office or person named in section 4. 

If we do not answer you or do not answer you satisfactorily within four weeks of receiving your request, you can contact the “Market Surveillance Body of the Federal States for the Accessibility of Products and Services (MLBF)”. These have not yet been announced by the federal states. We will add them as soon as possible.

• Companies and institutions with a fixed IP can have it activated for using DrugBasePlus. You can choose which of the databases you want to use. You can also decide how many users should be able to access at the same time (concurrent user).
• You can access DrugBasePlus with a username and password via the login service apotheken.de ID. It is the central login service of our company Deutscher Apotheker Verlag.
• Does your home institution use Shibboleth? We can then set up access for you using your existing login data.

Contact us at software@dav-medien.de!
Then we would be happy to advise you on which option is the best access option for your needs.

While booking, a number of concurrent users is agreed. The message shows that all the sessions available to your institution are occupied by colleagues. First a colleague has to log out before you can access. If necessary, speak to the administrator of your institution so that the number of simultaneous users can be increased.
 

The DrugBasePlus convenience search simultaneously searches all categories of a database for the search term entered. DrugBasePlus takes into account name fields and active substance details.

If you want to narrow down your search very specifically, our cross-references may be helpful (available for the ABDA database and the Index Nominum).

Messages are displayed for the duration recommended by the ABDA. A distinction is made according to categories:

• New introduction- 3 months

• Changes - 10 years
• Recall - 5 years
• Report from the federal institutes - 3 years
• AMK report- 10 years
• ABDATA report - 3 years
• Changes, economic- 1 month
• Changes, pharmaceutical - 6 months
• ABDA press releases- 1 month
• Launch of non-medicinal products - 3 years
• other informations - 10 years